Our practice is here for only one reason, and
that's you. We believe that the cancer treatment method offered here has the potential to be of significant
benefit to many patients and we believe that strongly enough to undertake the huge time and financial investment to offer
this opportunity to individuals facing tough cancer choices.
It's for the same reason that everything about
our offices and our practice has been geared toward letting you feel as relaxed as possible when you're here. We know
that our patients wouldn't be seeing us if they weren't facing some difficult times, so at least we can offer peaceful surroundings
that look more like your living room than a typical stainless-steel clinic.
You'll also know you're welcome
here when you meet our staff. Dr. Cantrell will tell you that he has carefully selected the best people anywhere to
make sure you're made comfortable and treated with dignity every step of the way. We think you'll agree. We know
there are some days when you'll look forward to sharing a story or something funny with us, and other days when a caring and
quiet smile may be the best medicine.
We look foward to having you here and we hope it may be the start of a friendship
lasting many a year.
our Medical Director
Dr. Stephen Cantrell founded NeoPlas Innovation and serves as our Medical Director.
Dr. Cantrell is a native of Huntsville, Alabama and a craniofacial and maxillofacial surgeon with the following educational
Madison Academy, Huntsville AL
Honor graduate, 1981, National Honor Society, student government president
David Lipscomb University, Nashville TN
Bachelor of science, 1984
(one year CLEP credit), summa cum laude, National Merit Scholar
Emory University School of Dentistry, Atlanta GA
Doctor of Dental Surgery, 1988, Robert W. Woodruff Fellow (full academic
School of Medicine, Nashville TN
Doctor of Medicine, 1991 (one year advanced standing)
Vanderbilt University Medical Center, Nashville TN
Residency in Oral &
Maxillofacial Surgery, 1988 - 1993 (with one year general surgery)
Australian Craniofacial Unit and Royal Adelaide Hospital
Plastic Surgery Division, Adelaide, South Australia
Fellowship in craniofacial and cleft
surgery, 1993 - 1994
Upon completing his education in 1994, Dr. Cantrell accepted a faculty position at the University
of Medicine and Dentistry of New Jersey where he was the founding director of the University Craniofacial Center of New Jersey
and oversaw the multidisciplinary care for the university's craniofacial and cleft lip & palate patients.
that a busy surgical career would never allow time to develop any meaningful cancer work, Dr. Cantrell made the
decision to change tracks and returned to Nashville in 2001 to devote full time to preparing and offering this treatment.
While deeply devoted to this work, he will tell you that his highest priorities of all are faith, family, and friends.
Among his hobbies are motorcycling, fitness, drums, guitar, reading, photography, audio-visual production, and amateur radio.
What's our story?
NeoPlas Innovation is a clinical cancer treatment firm in Brentwood (Nashville), Tennessee which is now accepting appropriately
selected patients for planning and treatment which may include a new outpatient combination treatment. Our preclinical
efforts began in 1997 because of our Medical Director's own urgent need for an effective treatment for stage IV melanoma.
The precise details of our unique combination therapy were devised in 2000. After Dr. Cantrell achieved a
complete response with his own malignancy, several other patients with pancreatic cancer and melanoma began treatment
the same year. With very encouraging early results in these aggressive malignancies and others, the technique is now
being offered for the first time to the public at large.
Our name is a play on words from a medical term.
NeoPlas (pronounced "NEE-oh-plaz") comes from neoplasm, the Latin-based medical term for a tumor or cancer.
So the name suggests what we do: an innovative new treatment technique for cancer. At the present time, it's not
available anywhere else.